Characteristics of Appendicitis After Immune Checkpoint Inhibitors Among Cancer Patients

被引：0
|
作者：
Mathew, Antony [1 ]
Shatila, Malek [2 ]
Lai, Zongshan [2 ]
Tan, Dongfeng [2 ]
Oliva, Isabella Glitza [2 ]
Wang, Jianbo [2 ]
Alhalabi, Omar [2 ]
Zhang, Hao Chi [2 ]
Thomas, Anusha S. [2 ]
Wang, Yinghong [2 ]
机构：
[1] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2022年 / 117卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S183
引用
收藏
页码：S133 / S134
页数：2
相关论文
共 50 条
  • [21] Efficacy of immune checkpoint inhibitors and age in cancer patients
    Huang, Xuan-zhang
    Gao, Peng
    Song, Yong-xi
    Sun, Jing-xu
    Chen, Xiao-wan
    Zhao, Jun-hua
    Wang, Zhen-ning
    IMMUNOTHERAPY, 2020, 12 (08) : 587 - 603
  • [22] Medication use among lung cancer patients before and after initiating immune checkpoint inhibitors: A population study.
    Mei, Chuchu
    Yang, Amy
    Shaver, Amy L.
    Nikita, Nikita
    Banks, Joshua
    Keith, Scott W.
    Lu-Yao, Grace L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [23] Obesity and cancer outcomes among patients with lung cancer and cutaneous melanoma treated with immune checkpoint inhibitors and EGFR inhibitors
    Nduaguba, Sabina O.
    Hazlehurst, Lori
    CANCER RESEARCH, 2024, 84 (06)
  • [24] Evaluation of immune checkpoint inhibitors rechallenge after immune-related adverse events in patients with cancer
    Tang, X-R.
    Li, R.
    Zhao, F.
    Wen, X.
    Wang, Y-K.
    Lv, R-X.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1269 - S1269
  • [25] Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer
    Simonaggio, Audrey
    Michot, Jean Marie
    Voisin, Anne Laure
    Le Pavec, Jerome
    Collins, Michael
    Lallart, Audrey
    Cengizalp, Geoffray
    Vozy, Aurore
    Laparra, Ariane
    Varga, Andrea
    Hollebecque, Antoine
    Champiat, Stephane
    Marabelle, Aurelien
    Massard, Christophe
    Lambotte, Olivier
    JAMA ONCOLOGY, 2019, 5 (09) : 1310 - 1317
  • [26] Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer
    Bui, Quang Loc
    Mas, Leo
    Hollebecque, Antoine
    Tougeron, David
    de la Fouchardiere, Christelle
    Pudlarz, Thomas
    Alouani, Emily
    Guimbaud, Rosine
    Taieb, Julien
    Andre, Thierry
    Colle, Raphael
    Cohen, Romain
    CANCERS, 2022, 14 (02)
  • [27] Immune-related musculoskeletal toxicities among cancer patients treated with immune checkpoint inhibitors: a systematic review
    Abdel-Rahman, Omar
    Eltobgy, Mostafa
    Oweira, Hani
    Giryes, Anwar
    Tekbas, Aysun
    Decker, Michael
    IMMUNOTHERAPY, 2017, 9 (14) : 1175 - 1183
  • [28] Cancer cachexia reduces the efficacy of immune checkpoint inhibitors in cancer patients
    Yu, Yean
    Yan, Li
    Huang, Tianhui
    Wu, Zhenfu
    Liu, Juan
    AGING-US, 2024, 16 (06): : 5354 - 5369
  • [29] Inpatient and ED Use Among Melanoma and Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
    Tay, Djin L.
    Dubose, Kline
    Meeks, Huong
    Guo, Jia-Wen
    Feldner, Katie
    Alekhina, Natalya
    Sheng, Xiaoming
    Chipman, Jonathan
    Ellington, Lee
    Hashibe, Mia
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2024, 67 (05) : E826 - E827
  • [30] Comparative risk of acute kidney injury among cancer patients treated with immune checkpoint inhibitors
    Liu, Fei
    Wang, Zixian
    Li, Xiaofan
    Zhang, Zhen
    Yang, Yue
    Chen, Junquan
    Chen, Dinghua
    Wu, Lingling
    Liu, Xiangyu
    Han, Sujun
    Wang, Fangming
    Wahafu, Wasilijiang
    Gao, Yibo
    Ren, Shancheng
    Xing, Nianzeng
    Cai, Guangyan
    Chen, Xiangmei
    CANCER COMMUNICATIONS, 2023, 43 (02) : 214 - 224
12345